Michael S. Ostrach

2011 - Dynavax Technologies

In 2011, Michael S. Ostrach earned a total compensation of $1.2M as Vice President, Chief Business and Principal Financial Officer and General Counsel at Dynavax Technologies.

Compensation breakdown

Non-Equity Incentive Plan$145,140
Option Awards$703,975
Salary$322,534
Other$28,212
Total$1,199,861

Ostrach received $704K in option awards, accounting for 59% of the total pay in 2011.

Ostrach also received $145.1K in non-equity incentive plan, $322.5K in salary and $28.2K in other compensation.

Rankings

In 2011, Michael S. Ostrach's compensation ranked 4,996th out of 10,747 executives tracked by ExecPay. In other words, Ostrach earned more than 53.5% of executives.

ClassificationRankingPercentile
All
4,996
out of 10,747
54th
Division
Manufacturing
1,800
out of 3,960
55th
Major group
Chemicals And Allied Products
377
out of 1,038
64th
Industry group
Drugs
233
out of 786
70th
Industry
Pharmaceutical Preparations
183
out of 571
68th
Source: SEC filing on April 28, 2014.

Ostrach's colleagues

We found six more compensation records of executives who worked with Michael S. Ostrach at Dynavax Technologies in 2011.

2011

Dino Dina

Dynavax Technologies

Chief Executive Officer

2011

J Martin

Dynavax Technologies

Chief Medical Officer

2011

Robert Coffman

Dynavax Technologies

Chief Scientific Officer

2011

Jennifer Lew

Dynavax Technologies

Former Vice President, Finance and Former Principal Accounting Officer

2011

Stephen Tuck

Dynavax Technologies

Former Vice President, Global Technical Operations

2011

Robert Janssen

Dynavax Technologies

Chief Medical Officer

News

In-depth

You may also like